EMV 3.27% $2.05 emvision medical devices ltd

- I like how EMV was last on the webinar behind the other 3...

  1. 970 Posts.
    lightbulb Created with Sketch. 529

    - I like how EMV was last on the webinar behind the other 3 company presentations. Keeping the viewers on and the more exciting game changer company out of the 4 presented today IMO.

    - Scott Kirkland presenter was direct, knowledgeable, confident and to the point.

    - Concept images for 2nd Gen device which is underway, miniaturising the 2nd Gen device, aim to be built middle of 2021

    - EMV has very clear images to see differences in human tissue

    - Feedback from FDA

    - ASA MRFF grant bid, 1 of 10 shortlisted, not sure how much government will fund maybe 1,2,3 but will have to wait and see.

    - Prof Stuart Crozier 2/3rd of MRIs use Prof Crozier developed IP is part of the EMV team, this is gold IMO in order to breakthrough this market

    - How do you get through the regulator pathway in Australia and other markets?

    o Submitted FDA 510(k)

    - 2nd Gen device, how small does it need to be and pathway to get to that point?

    o Early stage but have a wearable prototype, incredibly lightweight

    o VNA is the heaviest part of the headset designed by Keysight.

    - Would minor stroke be more difficult to detect?

    o Having a large no. of small strokes in the cohort

    - EMV intention is not to replace MRI

    - Competitor perspective?

    o Chicago 2019 Nov conference, NO ONE REALLY HAS REALLY QUITE LIKE EMV DEVICE

    o Aren’t able to localise and classify strokes and some hardware much larger than EMV

    o Big market

    o Lots of interest in market and EMV have a good head start

    - Big news flow pipeline coming.

 
watchlist Created with Sketch. Add EMV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.